​Migraine 

*Teva Pharmaceutical Industries
 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy of a Single Subcutaneous Dose of Fremanezumab on Subsequent Migraine Attacks in Patients with Migraine

*Protocol I5Q-MC-B004: preventive TReatment of mIgraine: oUtcoMes for Patients in real-world Healthcare systems (TRIUMPH)